Tanshinol A Ameliorates Triton‐1339W‐Induced Hyperlipidemia and Liver Injury in C57BL/6J Mice by Regulating mRNA Expression of Lipemic‐Oxidative Injury Genes

摘要

Abstract Tanshinol A, which is derived from a traditional Chinese herbal Radix Salviae Miltiorrhizae is indicative of a hypolipidemic candidate. Therefore, we aim to validate its hypolipidemic activity of tanshinol A and explore its mechanism in triton‐1339W‐induced hyperlipidemic mice model, which possess multiply pathogenesis for endogenous lipid metabolism disorder. Experimental hyperlipidemia mice are treated with or without tanshinol A (i.g. 40, 20, 10?mg/kg), and blood and liver tissue were collected for validating its hypolipidemic and hepatic protective effect, and hepatic mRNA expression profile, which was associated with lipid metabolism dysfunction and liver injury, was detected by RT‐qPCR. As results show, triton‐1339W‐induced abnormal of serum TC, TAG, HDL‐C, LDL‐C, SOD, MDA, GOT, and GPT is remarkably attenuated by tanshinol A. In pathological experiment, triton‐1339W‐induced hepatocellular ballooning degeneration, irregular central vein congestion, and inflammation infiltration are alleviated by tanshinol A. Correspondingly, hepatic mRNA expression of Atf4 , Fgf21 , Vldlr , Nqo1 , Pdk4 , and Angptl4 , which are genes regulating lipemic‐oxidative injury, are significantly increased by tanshinol A by 2~6 fold. Abcg5 , Cd36 , and Apob , which are responsible for cholesterol metabolism, are mildly upregulated. Noticeably, triton‐1339W‐suppressed expressions of Ptgs2/Il10 , which are genes responsible for acute inflammation resolution in liver injury, are remarkably increased by tanshinol A. Conclusively, tanshinol A exerted hypolipidemic effect and hepatoprotective effect through restoring triton‐1339W‐suppressed mRNA expression, which may be involved in Atf4/Fgf21/Vldlr and Ptgs2/Il‐10 signaling pathways.